KEAP1 and breast carcinoma: In conclusion, the authors confirmed that the genetic variants in the KEAP1 gene were associated with the outcomes of patients with breast cancer and that these SNPs may cause defects in the antioxidant defense mechanisms, underscoring the importance of the NRF2/KEAP1 signaling pathway.